Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946788 · ClinicalTrials.gov registry record · Phase 2
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
A Phase 2 study, sponsored by BioPharmX.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02946788: Completed Phase 2 study, sponsored by BioPharmX.
NCT02946788 is a Phase 2 study that has completed, run by BioPharmX. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02946788, a Phase 2 study, has completed, sponsored by BioPharmX.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.
Primary Outcome
difference in number of inflammatory lesions at week 12 as compared to baseline
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2018-06-01 |
| Phase | Phase 2 |
What the finished NCT02946788 record still lists
NCT02946788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT02946788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02946788 about?
NCT02946788 is a clinical study titled "Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel". This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.
What is the current status of trial NCT02946788?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2017-03-13. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT02946788?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT02946788?
This trial is sponsored by BioPharmX, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02946788's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI